These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 10446738)

  • 1. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mirtazapine versus selective serotonin reuptake inhibitors.
    Thompson C
    J Clin Psychiatry; 1999; 60 Suppl 17():18-22; discussion 46-8. PubMed ID: 10446737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant treatment of the depressed patient with insomnia.
    Thase ME
    J Clin Psychiatry; 1999; 60 Suppl 17():28-31; discussion 46-8. PubMed ID: 10446739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study.
    Pallanti S; Quercioli L; Bruscoli M
    J Clin Psychiatry; 2004 Oct; 65(10):1394-9. PubMed ID: 15491244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind, randomized, group-comparative study of the tolerability and efficacy of 6 weeks' treatment with mirtazapine or fluoxetine in depressed Chinese patients.
    Hong CJ; Hu WH; Chen CC; Hsiao CC; Tsai SJ; Ruwe FJ
    J Clin Psychiatry; 2003 Aug; 64(8):921-6. PubMed ID: 12927007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does mirtazapine have a more rapid onset than SSRIs?
    Quitkin FM; Taylor BP; Kremer C
    J Clin Psychiatry; 2001 May; 62(5):358-61. PubMed ID: 11411818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
    Thase ME; Nierenberg AA; Vrijland P; van Oers HJ; Schutte AJ; Simmons JH
    Int Clin Psychopharmacol; 2010 Jul; 25(4):189-98. PubMed ID: 20531012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E; Skarstein J; Behnke K; Agren H; Helsdingen JT
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mirtazapine: efficacy and tolerability in comparison with fluoxetine in patients with moderate to severe major depressive disorder. Mirtazapine-Fluoxetine Study Group.
    Wheatley DP; van Moffaert M; Timmerman L; Kremer CM
    J Clin Psychiatry; 1998 Jun; 59(6):306-12. PubMed ID: 9671343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of the clinical efficacy of mirtazapine.
    Benkert O; Muller M; Szegedi A
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S23-6. PubMed ID: 12404666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacologic rationale for the clinical use of antidepressants.
    Pinder RM
    J Clin Psychiatry; 1997 Nov; 58(11):501-8. PubMed ID: 9413422
    [No Abstract]   [Full Text] [Related]  

  • 12. Mirtazapine in major depression with comorbid generalized anxiety disorder.
    Goodnick PJ; Puig A; DeVane CL; Freund BV
    J Clin Psychiatry; 1999 Jul; 60(7):446-8. PubMed ID: 10453798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of SSRI-induced sexual dysfunction with mirtazapine treatment.
    Farah A
    J Clin Psychiatry; 1999 Apr; 60(4):260-1. PubMed ID: 10221289
    [No Abstract]   [Full Text] [Related]  

  • 14. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.
    Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O
    J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of mirtazapine in major depressive disorder patients after SSRI treatment failure: an open-label trial.
    Fava M; Dunner DL; Greist JH; Preskorn SH; Trivedi MH; Zajecka J; Cohen M
    J Clin Psychiatry; 2001 Jun; 62(6):413-20. PubMed ID: 11465517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
    Fawcett J; Barkin RL
    J Affect Disord; 1998 Dec; 51(3):267-85. PubMed ID: 10333982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mirtazapine versus fluoxetine on "sleep quality".
    Lawrence RW
    J Clin Psychiatry; 2004 Aug; 65(8):1149-50. PubMed ID: 15323610
    [No Abstract]   [Full Text] [Related]  

  • 19. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.